Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials

Standard Rate ◽

Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC)

10.1200/jco.2005.23.16_suppl.2024 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 2024-2024

Author(s):

R. A. Soo ◽

H. L. Lim ◽

L. Z. Wang ◽

L. S. Tham ◽

R. Soong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Fixed Dose Rate ◽

Standard Rate ◽

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdl084 ◽

2006 ◽

Vol 17 (7) ◽

pp. 1128-1133 ◽

Cited By ~ 33

Author(s):

R.A. Soo ◽

L.Z. Wang ◽

L.S. Tham ◽

W.P. Yong ◽

M. Boyer ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Fixed Dose ◽

Advanced Stage ◽

Small Cell Lung ◽

Fixed Dose Rate ◽

Standard Rate ◽

Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2006.12.015 ◽

2007 ◽

Vol 56 (2) ◽

pp. 263-271 ◽

Cited By ~ 4

Author(s):

Pasquale Comella ◽

Carlo Putzu ◽

Bruno Massidda ◽

Giovanni Condemi ◽

Giuseppe De Cataldis ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Dose Escalation ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Fixed Dose Rate ◽

Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2007.05.004 ◽

2007 ◽

Vol 58 (1) ◽

pp. 80-87 ◽

Cited By ~ 9

Author(s):

Jose R. Pereira ◽

Luis Fein ◽

Auro del Giglio ◽

César R. Blajman ◽

Eduardo Richardet ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Cell Lung Cancer ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Short Infusion ◽

Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FDR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC)

10.1200/jco.2004.22.14_suppl.7333 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7333-7333

Author(s):

O. Caffo ◽

A. Santo ◽

S. Binato ◽

M. Zucchetti ◽

A. Lucenti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Cell Lung Cancer ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FDR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC)

10.1200/jco.2004.22.90140.7333 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7333-7333

Author(s):

O. Caffo ◽

A. Santo ◽

S. Binato ◽

M. Zucchetti ◽

A. Lucenti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Cell Lung Cancer ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Celecoxib combined with fixed dose-rate gemcitabine (FDR-Gem)/CDDP as induction chemotherapy for stage III non-small cell lung cancer (NSCLC)

10.1200/jco.2005.23.16_suppl.7324 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7324-7324 ◽

Cited By ~ 1

Author(s):

M. Milella ◽

A. Ceribelli ◽

A. Gelibter ◽

P. Malaguti ◽

B. Di Cocco ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Fixed Dose ◽

Small Cell Lung ◽

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-003-0637-5 ◽

2003 ◽

Vol 52 (2) ◽

pp. 153-158 ◽

Cited By ~ 10

Author(s):

Ross A. Soo ◽

Hong L. Lim ◽

Ling Z. Wang ◽

How S. Lee ◽

Michael J. Millward ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Research Group ◽

Phase I Trial ◽

Cancer Therapeutics ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1255-7 ◽

2010 ◽

Vol 65 (6) ◽

pp. 1197-1202 ◽

Cited By ~ 7

Author(s):

Orazio Caffo ◽

Stefania Fallani ◽

Elena Marangon ◽

Stefania Nobili ◽

Maria Iris Cassetta ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Cell Lung Cancer ◽

Pharmacokinetic Study ◽

Small Cell ◽

Fixed Dose ◽

Small Cell Lung ◽

Prolonged Infusion ◽

P-218 Celecoxib combined with fixed dose-rate gemcitabine (FDR-Gem)/CDDP as induction chemotherapy for stage III non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)80712-3 ◽

2005 ◽

Vol 49 ◽

pp. S172

Author(s):

M. Milella ◽

A. Ceribelli ◽

A. Gelibter ◽

P. Malaguti ◽

F. Cecere ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Dose Rate ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Fixed Dose ◽

Small Cell Lung ◽